Scott Sieg

12PUBLICATIONS
57CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityNanoscale characterisationGene and molecular therapyAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Feb 17, 2026
Impact of COVID-19 Monoclonal Antibody Therapy on Subsequent Vaccine-Elicited SARS-CoV-2 Immune Responses.

Davey Smith, Isabelle R Weir, Sydney Ramirez

|Dec 19, 2025
Interleukin-2 is a potent latency reversal agent in people with treated HIV-1.

Michael L Freeman, Brian M Clagett, Konstantin Leskov

|Dec 04, 2023
Cytomegalovirus Infection Facilitates the Costimulation of CD57+CD28- CD8 T Cells in HIV Infection and Atherosclerosis via the CD2-LFA-3 Axis.

Nicole E Winchester, Soumya Panigrahi, Anokhi Haria

|Nov 13, 2023
Viral and host mediators of non-suppressible HIV-1 viremia.

Abbas Mohammadi, Behzad Etemad, Xin Zhang

|Oct 27, 2022
Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial.

Manish C Choudhary, Kara W Chew, Rinki Deo

|Mar 12, 2021
Probing the Interface of HIV and Inflammaging.

Scott F Sieg, Carey L Shive, Soumya Panigrahi

Pageof 2